In Vitro ADME Services

Frontage Global Drug Discovery Services (GDDS) offers a full spectrum of in vitro ADME assays for small molecule drug discovery and preclinical development. Our strong focus on lab operations, automation, and project management enables efficient delivery and unparalleled quality. We believe in a customer-centric approach providing real-time communication and reliable consultations to Sponsors.

"*" indicates required fields

First Name*

Last Name*

Company*

State*

Country

Email*

Phone*

Please only hit the submit button once.

I AGREE*

By submitting this form I agree that Frontage may process my data in the manner described in Frontage’s Privacy Policy.

Comments

This field is for validation purposes and should be left unchanged.

In Vitro ADME Services

Resources to Consider

IN Vitro Assessment of the inhibition of Human Organic Anion...

In Vitro BE Study in ANDA Drug Product Development

Stability Study for EMLA Cream Using In Vitro Percutaneous Absorption

An Unexpected Major Circulating Metabolite M219 Detected in...

Qualification of the Quanterix Phospho-Tau 217 (pTau-217) assay using...

Addressing the Increasing Needs of Data Integrity by Implementing the...

Nonclinical Vehicle Formulations:HP-β-CD...

Evaluating the feasibility of lyophilization for oral formulation...

A GxP-Qualified dPCR-Based RCL Assay to Quantify Replication...

Identification of the Major Circulating Metabolite of Mymd-1 And...

Quantitative Analysis of Oligonucleotide by Ion Paring Reversed-Phase...

A Hybrid Trial Approach by Combining 13C8-Lableded & Radiolabeled...